Now that AbbVie’s board has reversed course on the company’s plans to acquire Shire, the deal appears all but dead. That means that not only will Shire have to face the near future on its own again, but it casts doubt on the other big tax inversion deal with material implications in Massachusetts — that involving Covidien and Medtronic.
Help employers find you! Check out all the jobs and post your resume.
